Urban legend series: mucous membrane pemphigoid.

Area of Science:

• Immunodermatology
• Autoimmune blistering diseases
• Mucosal immunology

Background:

• Mucous membrane pemphigoid (MMP) is a group of autoimmune diseases with significant clinical and immunological variability.
• Key questions persist regarding its distinct subtypes, curability, optimal treatment, and relationship with other conditions.

Purpose of the Study:

• To investigate controversial aspects of mucous membrane pemphigoid (MMP).
• To clarify the status of oral pemphigoid (OP) and oral IgA dermatitis.
• To assess the curability and optimal therapeutic strategies for MMP.

Main Methods:

• Extensive literature searches were conducted to address four specific research questions.
• Analysis focused on clinical and immunological data from existing studies and case series.

Main Results:

• The distinct entity of oral pemphigoid (OP) within MMP remains uncertain.
• The curability of MMP and the necessity for long-term drug administration are unclear.
• High-quality therapeutic trials for MMP are scarce, and existing recommendations require potential updates, especially concerning sulfa drugs.
• No strong evidence supports oral IgA dermatitis as a separate entity from MMP.

Conclusions:

• Further research is needed to define subtypes and establish definitive treatment protocols for MMP.
• Current understanding of MMP necessitates cautious interpretation of existing guidelines and expert opinions.
• Clarification on the distinctness of OP and the long-term management of MMP is crucial for patient care.